Encore
Experience the talks from the NEI Psychopharmacology Congress and pre-conference Workshop again, or for the first time!
Select year: Available to guests!     lock
pre-conference workshop
Important Developments: Cannabinoid Effects at Different Stages of Life
Steven Parker James, MD

Learn more about the influence of cannabinoids on neurodevelopment through various life stages in this interesting and important presentation, by Dr. Steven James. In this talk, Dr. James addresses the relationship between cannabinoids and neurogenesis, the effect of cannabis use on brain development, and explores how the endocannabinoid system relates to neurotransmitters and important brain circuits.

CME credit: 0.75

Get started
Download slides (PDF)
Download audio: Click to listen or right click to download



Doobie Do or Doobie Don't? Where the Evidence Lies Regarding Cannabis Use
Kari L Franson, PharmD, PhD

What evidence exists to support the medicinal application of cannabis? What about when it comes to mental health? Can cannabis help or hurt? In this presentation, Dr. Kari Franson discusses the evidence for and against the use of cannabis for the treatment of various mental health issues.

CME credit: 1.00

Get started
Download slides (PDF)
Download audio: Click to listen or right click to download



Behind the Cannabis: Drug Interactions With Psychiatric Medications
Andrew J Cutler, MD; Deborah A York, MSN, PMHNP, APRN

In this exciting presentation, Dr. Andrew Cutler and psychiatric nurse practitioner, Deb York discuss important issues on this topic, including communication strategies on discussing cannabis use with patients, the role of pharmacokinetic testing, and how to effectively monitor patients who use cannabis concurrently with psychiatric medications.

CME credit: 0.75

Get started
Download slides (PDF)
Download audio: Click to listen or right click to download



NEI Psychopharmacology Congress
Addressing the Intolerable: Practical Strategies to Mitigate Psychotropic Side Effects
Rajnish Mago, MD

Side effects of psychotropic medications are common, bothersome, and a leading cause of treatment discontinuation. Here, Dr. Rajnish Mago will discuss some of the most common side effects of psychotropic medications, as well as evidence-based strategies for their clinical management.

CME credit: 1.00

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



From Orexin to Z-Drugs: A Clinical Update on Insomnia
Thomas L Schwartz, MD

Sleep is a little understood but critical activity in which every human takes part. Here, Dr. Thomas Schwartz discusses our current knowledge of the neurobiology of sleep as well as the recognition and diagnosis of insomnia. Additionally, Dr. Schwartz explores the mechanism of action and use of existing and novel treatments for insomnia.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Maternal Mental Health: Addressing Peri- and Postpartum Depression
Andrew J Cutler, MD

Utilization of psychotropic medications during the peripartum period can be a difficult and personal decision whereby medication-induced risks to the unborn child must be weighed against the risk of untreated mental illness. In this presentation, Dr. Andrew Cutler provides advice on how best to treat patients with mental illness both during and after pregnancy.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Challenges in the Management of Bipolar Disorder
Joseph F. Goldberg, MD

In this presentation, Dr. Joseph Goldberg discusses a variety of treatment strategies and best practices for optimizing care for patients with bipolar disorder.

CME credits: 1.25

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Out of the Pipeline: Novel Targets and Treatments for Schizophrenia
Andrew J Cutler, MD; Stephen M Stahl, MD, PhD, DSc (Hon)

Currently available treatments often do not ameliorate all symptoms of schizophrenia and are associated with obstinate adverse effects. In this presentation, Drs. Stephen Stahl and Andrew Cutler will review mechanisms and clinical evidence of emerging treatments that ameliorate schizophrenia, particularly its negative symptoms.

CME credit: 1.00

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Still Like That Old Time Pharmaco! When, Why, and How to Utilize Older Medication
Jonathan M Meyer, MD

With the advent of many newer and novel medications to treat mental illness, older medications such as clozapine and first-generation antipsychotics are often overlooked or considered too challenging to utilize. In this presentation, Dr. Jonathan Meyer explores the rationale and best practices for implementing some of these older medications into clinical practice.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Looking Over Dr. Stahl's Shoulder: Hot Topics from the Editor's Desk
Stephen M Stahl, MD, PhD, DSc (Hon)

Join Dr. Stephen Stahl, Editor-in-Chief of CNS Spectrums, as he discusses some of the most potentially practice-changing journal articles that have been recently published.

CME credit: 0.50

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



So Stimulating! Non-pharmacotherapy for Depression
William M Sauvé, MD

Brain stimulation has been an effective nonpharmacological treatment approach for treatment resistant depression (TRD), and a variety of other mental disorders. In this presentation, Dr. William Sauvé discusses the most current research findings on the efficacy and safety of transcranial magnetic stimulation, and other brain stimulation techniques for the treatment of psychiatric disorders.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



You Ruined Me: Mental Health in the Face of Early Life Adversity
Deborah A York, MSN, PMHNP, APRN

Childhood abuse and neglect are alarmingly common and are associated with poor mental health outcomes across the lifespan. Join Deborah York as she discusses the burgeoning field of neuroscience research investigating the influence of early life adversity on brain structure and function and the epigenome.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Food, Drink, and Meds: Important Interactions Between Food, Beverages, and Psychiatric Medications
Rajnish Mago, MD

Foods and beverages interact with certain psychiatric medications to alter their pharmacokinetic properties, resulting in potentially unintended health outcomes. Here, Dr. Rajnish Mago describes common foods and beverages that interact with psychiatric medications, and provides recommendations for avoiding unintended food-drug interactions.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Practical Treatment Strategies for Adults With ADHD
David W Goodman, MD, FAPA

When it comes to treating ADHD, there are many practical implications to consider. In this presentation, Dr. David Goodman addresses important considerations, such as medication options, and ways to reduce stimulant side effects.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Let's Get to the Point: Why We Should Include Long-Acting Injectables in the Treatment of Schizophrenia
Leslie Citrome, MD, MPH

Poor adherence to antipsychotic medication is common and drives poor outcomes. In this presentation, Dr. Leslie Citrome makes the case for why long-acting injectables are an invaluable resource for improving outcomes in patients with schizophrenia, and also addresses how the COVID-19 Public Health Emergency has (or has not) affected LAIs as an option.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Out of the Pipeline: What Next? Optimizing Outcomes for Treatment-Resistant Depression
Andrew J Cutler, MD; Roger S McIntyre, MD, FRCPC

One-third of depressed patients do not achieve an adequate clinical response to available treatment and are considered to have treatment-resistant depression. In this presentation, Drs. Andrew Cutler and Roger McIntyre discuss new research and therapeutic options for identifying and treating resistant depression.

CME credits: 1.25

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Combining Psychotherapy and Psychopharmacology: Rationale, Application, and Outcomes
Thomas L Schwartz, MD

Combining medication and psychotherapy may enable more effective treatment of various mental health conditions. Here, Dr. Thomas Schwartz discusses the evidence for combined treatment and provides practice-based-tools to improve patient outcomes.

CME credit: 1.00

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Breaking Bad: What To Do When Your Patient is Using Methamphetamine
William M Sauvé, MD

In this case-centered presentation, Dr. William Sauvé explores diagnostic and treatment strategies for patients with current or past methamphetamine use disorder.

CME credit: 1.00

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



I Feel It In My Gut: The Brain and Microbiome
Roger S McIntyre, MD, FRCPC

In this presentation, Dr. Roger McIntyre will review early preclinical data and a conceptual framework that supports a role for the gut-brain connection in the treatment of mental illness.

CME credit: 0.50

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Systematic Racism and its Impact on the Mental and Physical Health of Black Americans
Napoleon Bonaparte Higgins, Jr., MD

In this presentation, Dr. Napoleon Higgins takes an in depth look at how systemic racism has impacted the mental and physical health of Black Americans.

CME credits: 1.25

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Neurology for the Psychiatrist
Laxman B. Bahroo, DO

In this presentation, Dr. Laxman Bahroo examines the neurobiology behind a variety of neurological syndromes and how to distinguish them.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Psychiatry's Role in Tackling the Opioid Crisis: How to Optimize Medication-Assisted Treatment
William M Sauvé, MD

Opioid use disorder is a growing issue in the world but there are several medication-assisted treatment strategies available to aid patients in discontinuing opioid abuse. Here, Dr. William Sauvé reviews the neurobiology of the opioid system and discusses mechanism of action and application of treatments for individuals addicted to opioids.

CME credit: 1.00

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



The Most Common Condition You're Not Diagnosing: Binge Eating Disorder
William M Sauvé, MD

Although greatly underdiagnosed, binge eating disorder (BED) is the most common eating disorder and has a high risk of psychiatric and medical comorbidities. In this presentation, Dr. William Sauvé discuss the presenting symptoms of BED, as well as how to diagnose and treat BED.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Agitation and Psychosis in Dementia: Practical Management
Laxman B. Bahroo, DO

Patients with dementia often experience symptoms of psychosis and agitation. Improved diagnosis of these symptoms will allow for more appropriate treatment for these patients. In this presentation, Dr. Laxman Bahroo discusses the neurobiological basis for psychosis and agitation in patients with dementia, along with the most current evidence-based treatments.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Nothing to Worry About: Treatment Refractory Anxiety Disorders
Jeffrey Strawn, MD

In this presentation Dr. Jeffrey Strawn reviews evidence-based guidelines for implementing anti-anxiety medications as well as strategies for when first-line treatments fail to yield a full response.

CME credits: 1.25

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download